Company / Current Liabilities
Cartesian Therapeutics, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.9M
FY2025
5-year range
$14.9M / $72.3M
FY2021-FY2025
Trend
-35.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 8 years, ranging from $14M in FY2016 to $82M in FY2020.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -28.8%.
Improved from $68M to $15M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -15.9%
- 5-Year CAGR
- -28.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -28.8%, indicating a declining trend.
- In FY2025, current liabilities decreased 35.0% year-over-year.
- Peak current liabilities was recorded in FY2020.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.9M | -35.0% |
| FY2024 | $23.0M | -66.3% |
| FY2023 | $68.2M | +172.0% |
| FY2022 | $25.1M | -65.3% |
| FY2021 | $72.3M | -11.4% |
| FY2020 | $81.5M | +133.4% |
| FY2019 | $34.9M | +154.9% |
| FY2016 | $13.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026